Bank of America’s Kestra Medical Technologies KMTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.03M Sell
51,479
-4,686
-8% -$110K ﹤0.01% 4514
2025
Q4
$1.49M Buy
56,165
+34,574
+160% +$890K ﹤0.01% 4280
2025
Q3
$513K Buy
21,591
+13,325
+161% +$238K ﹤0.01% 5774
2025
Q2
$137K Sell
8,266
-620
-7% -$13.5K ﹤0.01% 6356
2025
Q1
$221K Buy
+8,886
New +$204K ﹤0.01% 6118

Other funds holding KMTS

Bank of America's KMTS Position: Q1 2026 in Review

Bank of America reduced its Kestra Medical Technologies (KMTS) stake by 8.3% in Q1 2026, selling an estimated $110K and leaving 51,479 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #4514.

Bank of America first reported a position in KMTS in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.49M in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Bank of America held 51,479 shares of Kestra Medical Technologies worth $1.03M as of Q1 2026.
  • Bank of America sold 4,686 Kestra Medical Technologies shares in Q1 2026, an estimated $110K.
  • Kestra Medical Technologies made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4514 holding.
  • Bank of America first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 5 quarters since.
  • Bank of America's Kestra Medical Technologies position peaked at $1.49M in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.